Cannabinoid

From Citizendium, the Citizens' Compendium
Jump to: navigation, search
This article is a stub and thus not approved.
Main Article
Talk
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and not meant to be cited; by editing it you can help to improve it towards a future approved, citable version. These unapproved articles are subject to a disclaimer.

In pharmacology, cannabinoids are "compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are tetrahydrocannabinol; cannabinol; and cannabidiol."[1]

Synthetic cannaboids, known as K2, Spice, Demon or Genie are also used for narcotic actions.[2][3]

Medical uses

Cannabinoids may reduce vomiting from chemotherapy.[4]

Cannabinoids do not seem to help dementia.[5]

Dronabinol, in a single study, may be worse than placebo for neuropathic pain associated with spinal cord injury.[6]

References

  1. Anonymous (2015), Cannabinoid (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Gay M (July 10, 2010). Synthetic Marijuana Spurs State Bans (English). New York Times. Retrieved on 2010-07-11.
  3. Anonymous. Spice Cannabinoid - JWH-018 (English). United States Department of Justice Drug Enforcement Administration. Retrieved on 2010-07-11.
  4. Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K et al. (2010). "Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.". Cochrane Database Syst Rev (9): CD007786. DOI:10.1002/14651858.CD007786.pub2. PMID 20824866. Research Blogging.
  5. Krishnan S, Cairns R, Howard R (2009). "Cannabinoids for the treatment of dementia.". Cochrane Database Syst Rev (2): CD007204. DOI:10.1002/14651858.CD007204.pub2. PMID 19370677. Research Blogging.
  6. Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala YJ et al. (2013). "Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury.". J Pain Res 6: 539-47. DOI:10.2147/JPR.S45966. PMID 23874121. PMC PMC3712802. Research Blogging.